RecruitingNot applicableNCT07195994

A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes

Studying MODY

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
QuickSilver Scientific
Principal Investigator
David Crowley, MD
KGK Science Inc.
Intervention
AMPK Charge+®(dietary_supplement)
Enrollment
90 target
Eligibility
18 years · All sexes
Timeline
20262026

Study locations (1)

Collaborators

KGK Science Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07195994 on ClinicalTrials.gov

Other trials for MODY

Additional recruiting or active studies for the same condition.

See all trials for MODY

← Back to all trials